Volume 9, Number 2—February 2003
Research
Using Hospital Antibiogram Data To Assess Regional Pneumococcal Resistance to Antibiotics
Table 2
Comparison of surveillance systems tracking Streptococcus pneumoniae susceptibility to select antimicrobial agents, United States, 1997–2000a
Percentage of all isolates susceptible to |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Year | Studyc | Penicillin | Erythro-mycind | Cefotaxime | Levo-floxacine | Tmp-smxd | Tetracyline | Clinda-mycin | Vanco-mycin | Chloram-phenicol |
1997 | ABC (2–5) TRUST (9–12) | 75 67 | 85 81 | 87 87 | 96 97 | 71 –– | –– –– | –– –– | 100 –– | –– –– |
NC | 63 | 69 | 80 | 100 | 57 | 79 | 76 | 100 | 95 | |
1998 | ABC Doern (7–8) TRUST | 76 70 65 | 85 81 77 | 86 –– 88 | 100 98 100 | 71 69 68 | –– 87 –– | –– 94 –– | 100 –– 100 | –– 93 –– |
NC | 56 | 64 | 83 | 92 | 51 | 83 | 88 | 100 | 89 | |
1999 | ABC TRUST | 73 67 | 80 77 | 83 85 | 100 99 | 68 66 | –– –– | –– –– | 100 100 | –– –– |
NC | 54 | 61 | 80 | 94 | 51 | 84 | 85 | 100 | 92 | |
2000 | ABC Doern RESP (13) TRUST | 73 66 84 66 | 78 74 66 73 | 82 –– 95 83 | 100 99 100 99 | 68 64 70 65 | –– 83 80 –– | –– 81 89 93 | 100 –– 100 100 | –– 92 –– –– |
NC | 52 | 61 | 77 | 99 | 50 | 81 | 88 | 100 | 94 |
aTmp-smx, trimethoprim-sulfamethoxazole; ABC, Active Bacterial Core Surveillance; TRUST, Tracking Resistance in the United States Today; RESP, Respiratory Surveillance Program.
bIf the surveillance overlapped two calendar years while covering one respiratory season, data were classified by the latter year. For example, isolates collected from October 1999 to April 2000 were labeled as year 2000 data.
cData for only invasive isolates (ABC); respiratory and invasive isolates (Doern, TRUST, NC); only respiratory isolates (RESP)
d1997–1999 TRUST data are for clarithromycin.
e1997 ABC data are for ofloxacin; all Doern data are for ciprofloxacin.